» Articles » PMID: 29733108

Reliability of Serum Creatinine-based Formulae Estimating Renal Function in Non-critically Ill Surgery Patients: Focus on Augmented Renal Clearance

Overview
Specialties Pharmacology
Pharmacy
Date 2018 May 8
PMID 29733108
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

What Is Known And Objectives: Formulae estimating glomerular filtration rate (GFR) are frequently used to guide drug dosing. The objectives of this prospective single-center study were to evaluate agreement between these equations and measured creatinine clearance (CrCl) in non-critically ill surgery patients with normal kidney function and augmented renal clearance (ARC, CrCl ≥ 130 mL/min/1.73 m²), to determine predictors for disagreement, define a GFR estimator cut-off value identifying ARC and determine the ARC prevalence and duration in non-critically ill surgical patients.

Methods: Hospitalized adult non-critically ill abdominal and trauma surgery patients were eligible for inclusion. Measured CrCl based on an 8-hour urinary collection (CrCl ) was used as the primary method for determining kidney function. Agreement between equations and measured CrCl was assessed in terms of precision, defined as a bias within ±10 mL/min/1.73 m². Predictors for disagreement were identified for the most precise estimator using an ordinal logistic regression model with negative bias, agreement and positive bias as outcome variables. A receiver operating characteristic (ROC) analysis was performed to identify an estimator cut-off predicting ARC, which was subsequently applied for the daily proportion of patients displaying ARC and ARC duration.

Results And Discussion: During the study period (14/11/2013 - 13/05/2014), in 232 adult non-critically ill abdominal and trauma surgery patients, all estimators tend to underestimate CrCl (mean bias ranging from 17 to 22 mL/min/1.73 m²), especially in patients displaying ARC (mean bias ranging from 44 to 56 mL/min/1.73 m²). eGFR performed the best. Younger age and low ASA score independently predicted underestimation of CrCl . Three different eGFR cut-offs with decreasing sensitivity and increasing specificity (84, 95 and 112 mL/min/1.73 m²) identified, respectively, 65%, 44% and 14% patients displaying ARC. The median ARC duration was 4, 4 and 3 days, respectively.

What Is New And Conclusion: In surgical patients, eGFR frequently underestimates measured CrCl, especially in young patients with low ASA score. eGFR cut-offs predicting ARC were identified.

Citing Articles

Optimize Vancomycin Dose in Surgical Ward Patients with Augmented Renal Clearance Determined by Chronic Kidney Disease Epidemiology Collaboration Equation.

Chen L, Wang C, Lin C, Tsai M, Shen W, Li P Infect Drug Resist. 2024; 17:4195-4203.

PMID: 39355780 PMC: 11444064. DOI: 10.2147/IDR.S477414.


Does Cytokine-Release Syndrome Induced by CAR T-Cell Treatment Have an Impact on the Pharmacokinetics of Meropenem and Piperacillin/Tazobactam in Patients with Hematological Malignancies? Findings from an Observational Case-Control Study.

Liu C, Cojutti P, Giannella M, Roberto M, Casadei B, Cristiano G Pharmaceutics. 2023; 15(3).

PMID: 36986882 PMC: 10059857. DOI: 10.3390/pharmaceutics15031022.


Measuring Creatinine Clearance Is the Most Accurate Way for Calculating the Proper Continuous Infusion Meropenem Dose for Empirical Treatment of Severe Gram-Negative Infections among Critically Ill Patients.

Troisi C, Cojutti P, Rinaldi M, Laici C, Siniscalchi A, Viale P Pharmaceutics. 2023; 15(2).

PMID: 36839872 PMC: 9967919. DOI: 10.3390/pharmaceutics15020551.


Discordance of renal drug dosing using estimated creatinine clearance and measured urine creatinine clearance in hospitalized adults: A retrospective cohort study.

Brown A, Lavelle R, Gerlach A Int J Crit Illn Inj Sci. 2020; 10(Suppl 1):1-5.

PMID: 33376682 PMC: 7759072. DOI: 10.4103/IJCIIS.IJCIIS_61_19.


Urinary Creatinine Clearance and Pharmacokinetics Studies: If We Can Measure It, Why Do We Estimate It?.

Silva C, Udy A, Baptista J Antimicrob Agents Chemother. 2020; 64(9).

PMID: 32571825 PMC: 7449153. DOI: 10.1128/AAC.00980-20.